Plunkett Research Online: Marizyme Inc

MARIZYME INC (MRZM:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Marizyme Inc is a biotechnology company. The company focuses on the treatment of acute ischemic stroke, acute myocardial infarction, deep vein thrombosis and chronic wounds/burns with clinically tested and use of protease therapeutic platform. Its product and product candidates include DuraGraft, a .....



Marizyme Inc
Ticker: MRZM
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 970 295-4372
Fax:
Address: 555 Heritage Drive
Suite 200
Jupiter, FL 33458 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Biological Product (except Diagnostic) Manufacturing
Contacts Description
Markus Ernst CFO/Chief Accounting Officer
Joerg Ott Chairman of the Board/Director
See More
Marizyme Inc is a biotechnology company. The company focuses on the treatment of acute ischemic stroke, acute myocardial infarction, deep vein thrombosis and chronic wounds/burns with clinically tested and use of protease therapeutic platform. Its product and product candidates include DuraGraft, a .....See More See More

Auditor: WithumSmith+Brown, PC
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: